Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Oncolytics Biotech Inc T.ONC

Alternate Symbol(s):  ONCY

Oncolytics Biotech Inc. is a biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and adaptive immune... see more

Bullboard (TSX:ONC)

View:
Post by Peladawnon Apr 15, 2024 6:40pm

US stepping up escalation in Middle East!…..

Speculation has it that Biden is threatening to say "Don't" twice!
Post by fasttrack5on Apr 15, 2024 4:58pm

Post on Linkedin

Great discussion about viral approaches in oncology with Daniel Sterman and Candel Therapeutics, who have a drug candidate targeting resectable #PancreaticCancer. Having a focus on pancreatic cancer ...more  
Comment by Noteableon Apr 15, 2024 2:43pm

RE:RE:RE:How does Accelerated Approval work

In the case of ONCY's biomarker driven registration studies, the number of enrolled patients for a Phase3/4 post approval confirmatory trial should be nominal due to the nature of the number of ...more  
Comment by Noteableon Apr 15, 2024 2:38pm

RE:RE:How does Accelerated Approval work

In the case of Orphan / Rare diseases and in diseases with unmet treatement needs, the FDA appears to have a tendency to grant  drug Accelerated Approvals much quicker than otherwise, and they do ...more  
Comment by inthnoon Apr 15, 2024 2:35pm

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:Quentin30 is a pathological prevaricator.

Hey note, now that last post of yours is one we both can agree on. Hopefully something substantial from the company before the agm
Comment by Noteableon Apr 15, 2024 2:13pm

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:Quentin30 is a pathological prevaricator.

With respect to " ...someone needs to talk to Allison and.straigjten her out hey note and btw no AA until after the phase 3.trials start..."  I agree, however, ONCY or it acquirer, ...more  
Comment by Azzak34on Apr 15, 2024 2:07pm

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:Quentin30 is a pathological prevaricator.

Inthno you make a whole bunch of them while accusing others of doing the same.  Spend more time researching your opinions, then post them instead of knee jerk reactionary therapy sessions. 
Comment by Azzak34on Apr 15, 2024 2:05pm

RE:RE:RE:RE:RE:RE:Quentin30 is a pathological prevaricator.

Couple of things Quent. You claim to have been here for years, claim to be in the biotech industry and you are being corrected on a near daily basis. Again, you're either lying about you're ...more  
Comment by inthnoon Apr 15, 2024 2:05pm

RE:RE:RE:RE:RE:RE:RE:RE:RE:Quentin30 is a pathological prevaricator.

At least I admit if I make a mistake unlike others and so which process is onc using for storage and distribution. I guess someone needs to talk to Allison and.straigjten her out hey note and btw no ...more  
Comment by Noteableon Apr 15, 2024 1:54pm

RE:RE:RE:RE:RE:RE:Quentin30 is a pathological prevaricator.

It is all about "scale-up" in advance of registration trials in support of Accelerated Approval and product commercilization. How many times does this have to be repeated for some?
Comment by Quentin30on Apr 15, 2024 1:48pm

RE:RE:RE:RE:RE:Quentin30 is a pathological prevaricator.

well whatya know... ONCY had their manufacturing process all sorted out 15 years ago...  Wonder what all the fluff and fluster was about at the last quarterly then... Probably just filling in ...more  
Comment by Noteableon Apr 15, 2024 1:46pm

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:Quentin30 is a pathological prevaricator.

we have already established lonc17's lack of ownership in ONCY.
Comment by Noteableon Apr 15, 2024 1:41pm

RE:RE:RE:RE:RE:RE:RE:RE:RE:Quentin30 is a pathological prevaricator.

Should read: " ... following the standard model of product lyophilization, storage and distribution..."
Comment by Noteableon Apr 15, 2024 1:39pm

RE:RE:RE:RE:RE:RE:RE:RE:RE:Quentin30 is a pathological prevaricator.

inthno is De_man (Steve) on the Stocktwits message board and being from Alberta, he lives on conspiracy theories.  
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities